Castle Biosciences, Inc. (CSTL)
40.79
+0.02
(+0.05%)
USD |
NASDAQ |
Jan 15, 16:00
40.79
0.00 (0.00%)
After-Hours: 16:41
Castle Biosciences SG&A Expense (TTM): 222.56M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 304.67M |
| Delcath Systems, Inc. | 40.02M |
| Star Operating Cos., Inc. | 23.32M |
| CorMedix, Inc. | 75.56M |
| CytoSorbents Corp. | 38.05M |